US Stock MarketDetailed Quotes

CLRB Cellectar BioSciences

Watchlist
  • 3.3000
  • -0.0300-0.90%
Close May 17 16:00 ET
118.30MMarket Cap-1067P/E (TTM)

Cellectar BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cellectar BioSciences Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.74

+2.63%
Analyst Rating

Strong Buy

May 15, 2024

Cellectar BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 27, 20242023/Q40.000 / 0.000--
Nov 2, 20232023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 27, 20242023/Q40.000 / 0.000--
Nov 2, 20232023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Cellectar BioSciences Earnings Reports

  • Cellectar BioSciences | 10-Q: Quarterly report

    May 14 05:34

  • Cellectar BioSciences | 10-K/A: Annual report (Amendment)

    Apr 1 16:04

  • Cellectar BioSciences | 10-K: Annual report

    Mar 27 05:34

  • Cellectar BioSciences: Q3 2023 Earnings Report

    Nov 13, 2023 05:30

    • Read more

    Analysis

    Analyst Rating

    Updated: May 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg